Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Consolidated revenues by Business
Analytical Instruments$7.55B+0.8%$7.55B+1.2%$7.53B+2.9%$7.44B+2.5%$7.49B+3.7%
Laboratory Products and Biopharma Services$24.38B$23.98B$23.54B$23.31B
Life Sciences Solutions$10.67B+10.1%$10.37B+7.7%$10.03B+5.6%$9.83B+3.0%$9.69B+0.4%
Specialty Diagnostics$4.67B+2.6%$4.68B+3.6%$4.61B+3.4%$4.57B+3.5%$4.55B+3.3%
Consolidated revenues by Product
Consumables$19.03B+8.1%$18.66B+6.1%$18.16B+4.1%$17.86B+2.9%$17.61B+1.1%
Instruments$7.23B-2.9%$7.3B-1.9%$7.33B+1.3%$7.29B-0.7%$7.45B+0.9%
Service revenues$18.94B+6.1%$18.59B+4.2%$18.25B+3.1%$18.07B+2.3%$17.84B+0.8%
Consolidated revenues by Geography
Asia-Pacific$8.18B+2.4%$8.1B+1.8%$8.03B+2.5%$7.94B+1.5%$7.99B+3.1%
Europe$12.16B+11.9%$11.83B+8.9%$11.35B+5.0%$11.03B+2.4%$10.86B+1.0%
North America$23.23B+3.2%$23.03B+2.4%$22.79B+2.5%$22.69B+1.7%$22.5B0.0%
Other regions$1.63B+5.2%$1.6B+2.3%$1.57B+5.7%$1.56B+7.9%$1.55B+4.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does Thermo Fisher Scientific break its business down?
Thermo Fisher Scientific (TMO) reports consolidated revenues by business across 4 parts — Analytical Instruments, Laboratory Products and Biopharma Services, Life Sciences Solutions and Specialty Diagnostics. Each is extracted from the segment footnotes and tracked over time.
Where does Thermo Fisher Scientific's segment data come from?
Segment breakdowns are pulled from the segment footnotes in Thermo Fisher Scientific's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.